PharmaLectures.com

Courses › Pharma training by role › Pharmacovigilance and medical: everything Europe expects of you, in one course

Pharmacovigilance and medical: everything Europe expects of you, in one course

Your safety team reports on time and answers inspectors the first time they ask.

  • 10 audio modulesthree lengths each
  • 1 h 40 min to 8 h 20 minbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Pharmacovigilance and medicalwho it is written for

Why this training matters

An inspector from a national competent authority opens your records and finds an adverse event report sent after its deadline. The team drops its work to write a Corrective and Preventive Action plan, and the Qualified Person is pulled into every call. Trust with the authority takes the hit.

What changes after this course

Your team classifies, reports and escalates cases by Good Pharmacovigilance Practices, and answers inspectors in the correct terms. You hold a certificate per learner and a training record per person for your compliance binder.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your deputy no longer waits for the Qualified Person to come back from leave. A request from a national competent authority arrives, and the deputy opens the Pharmacovigilance System Master File, applies Good Pharmacovigilance Practices Module I and Module II, and sends the answer. Legal is not asked to translate what the guideline already says.

A report lands in the safety mailbox on Friday afternoon. Your officer sees at once whether it is serious, when the clock started, and what goes to EudraVigilance and when. Signals get the same treatment: detection, validation, assessment and recommendation, each step written down as Module IX describes, so nothing sits without an owner.

The Risk Management Plan stops being a blank page. Your specialists write the safety specification first, then the plan that answers it, and build Periodic Safety Update Reports to Module VII with the benefit-risk conclusion up front. Imposed Post-Authorisation Safety Study protocols reach the Pharmacovigilance Risk Assessment Committee with a clear objective, so fewer questions come back.

A medical information call mentions a rash after the second dose. Medical Affairs recognises a reportable event, completes the handover note and passes it to pharmacovigilance the same day. Your forms and procedures state their lawful basis under the General Data Protection Regulation, so the next inspector can match what you do to what you wrote down.

Who needs this training

  • Pharmacovigilance Officer

    You open a report late on a Friday, unsure whether the clock has started and which term fits. After this course the decision is quick and the EudraVigilance submission leaves on time.

  • Medical Affairs Manager

    A medical information request mentions a side effect almost in passing. You recognise a reportable event, write the handover and send it to pharmacovigilance before the day ends.

  • Regulatory Affairs Specialist

    The Risk Management Plan is due and the template is empty. You start with the safety specification and know what the regulator expects under each heading.

  • Deputy Qualified Person for Pharmacovigilance

    The Qualified Person is on leave and an authority writes with a short deadline. You answer from the Pharmacovigilance System Master File under Module I without waiting for anyone.

  • Pharmacovigilance Quality Manager

    An inspection date is announced. You prepare your team to answer in the inspector's terms and have a Corrective and Preventive Action plan layout ready for any finding.

Roles: Pharmacovigilance and medical

Businesses: every kind of pharma company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Decide at intake whether an adverse event report is serious and when its reporting clock started.
  2. Submit Individual Case Safety Reports to EudraVigilance inside the 15-day and 90-day limits.
  3. Write a Risk Management Plan whose safety specification matches the pharmacovigilance plan built on it.
  4. Structure a Periodic Safety Update Report around the benefit-risk evaluation that Module VII requires.
  5. Run a safety signal from detection to recommendation using the steps in Module IX.
  6. Answer an inspector's question in correct regulatory terms and record the follow-up in a Corrective and Preventive Action plan.
  7. Route an adverse event found in a medical information request to the safety database with a complete handover note.

What the company gets

  • Your Pharmacovigilance System Master File is ready for the day an authority asks for it.
  • Individual Case Safety Reports leave for EudraVigilance with the reporting clock already checked at intake.
  • Your Risk Management Plans and Post-Authorisation Safety Study protocols arrive at the regulator in the shape it expects.
  • Inspectors get short, accurate answers, and you hold a certificate per learner and a training record per person to show for it.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 10 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing1 h 40 min10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard4 h 10 min25 min a module, for regulatory, quality and business-development staff
Expanded8 h 20 min50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Pharmacovigilance and medicalStandard4 h 10 min

Course outline: 10 modules

10 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Build a Pharmacovigilance System Master File that meets European rules

    • How to lay out the Pharmacovigilance System Master File so an inspector finds each answer in one pass.
    • The documents Module II expects in the file, so nobody hunts for them on the day the request arrives.
    • What to do when an authority asks for your file and part of it sits with a partner company.
  2. 2Appoint your Qualified Person for Pharmacovigilance under Module I

    • Why your Qualified Person must be based in the European Union, and what that means for staffing.
    • The duties to write into the deputy's role before the primary person goes on leave.
    • How to show an inspector your Qualified Person has real access to the system, not just a name on paper.
  3. 3Submit Individual Case Safety Reports to EudraVigilance on time

    • How to read an adverse event report at intake and know whether the reporting clock has already started.
    • The 15-day and 90-day deadlines, and which kind of report falls under each one.
    • What to do when a wrong medical term is already in EudraVigilance, and who corrects it.
  4. 4Detect safety signals and assess risk under Module IX

    • How to sort a flood of safety data into the few findings that deserve a signal review.
    • The steps Module IX sets from detection to recommendation, so each signal has a named owner.
    • Why a dismissed signal needs a written reason, and what that reason must show an inspector.
  5. 5Write Risk Management Plans that European regulators accept

    • How to write the safety specification first, so the pharmacovigilance plan follows from it.
    • The line between routine and additional risk minimisation measures, and who decides which applies.
    • When a regulator's comment means a new plan version, and when a short written reply is enough.
  6. 6Draft Periodic Safety Update Reports to Module VII rules

    • How to build a Periodic Safety Update Report around the benefit-risk evaluation, not the line listings.
    • Where to find your product's submission dates in the European Union reference dates list.
    • What to do when the assessment comes back with a request for supplementary information.
  7. 7Design Post-Authorisation Safety Studies under Module VIII

    • How to write a study objective that answers one named safety concern and nothing else.
    • When a study is imposed and when it is voluntary, and what that changes for your submission.
    • The design flaw that makes a finished study unusable, and how to catch it while the protocol is a draft.
  8. 8Answer inspector questions in pharmacovigilance audits and inspections

    • How to answer the question the inspector asked, in the words the inspector used, and stop there.
    • What to do in the room when an inspector points to a late report in your own records.
    • The Corrective and Preventive Action plan layout that gives each fix an owner and a date.
  9. 9Route safety data from Medical Affairs to your pharmacovigilance team

    • How to spot a reportable adverse event inside a routine medical information request.
    • The handover note that carries a case from Medical Affairs to the safety database without a second call.
    • Why a short written agreement between departments settles who owns a case before a deadline is at risk.
  10. 10Adapt pharmacovigilance processes to the General Data Protection Regulation

    • How to name your lawful basis for processing patient safety data, and where to write it down.
    • What to change in your adverse event forms so reporters' personal details are collected correctly.
    • When artificial intelligence tools touch case data, and what your procedures must say about it.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

10 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 1 h 40 min in the briefing length and 8 h 20 min in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Pharmacovigilance and medical. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 90 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team